Adamant Biomedical Investments as of Sept. 30, 2014
Portfolio Holdings for Adamant Biomedical Investments
Adamant Biomedical Investments holds 96 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 5.2 | $21M | 196k | 106.45 | |
| Celgene Corporation | 4.9 | $20M | 207k | 94.78 | |
| Biogen Idec (BIIB) | 4.5 | $18M | 55k | 330.81 | |
| Amgen (AMGN) | 3.5 | $14M | 100k | 140.46 | |
| Actavis SHS | 3.1 | $13M | 52k | 241.28 | |
| Salix Pharmaceuticals | 3.0 | $12M | 78k | 156.25 | |
| UnitedHealth (UNH) | 2.8 | $11M | 128k | 86.25 | |
| Mylan | 2.6 | $11M | 230k | 45.49 | |
| Auris Med Hldg | 2.5 | $10M | 2.2M | 4.61 | |
| Alexion Pharmaceuticals | 2.5 | $9.9M | 60k | 165.82 | |
| Medtronic | 2.3 | $9.3M | 150k | 61.95 | |
| Abbott Laboratories (ABT) | 2.1 | $8.3M | 200k | 41.59 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.0 | $8.2M | 73k | 112.32 | |
| McKesson Corporation (MCK) | 2.0 | $8.0M | 41k | 194.66 | |
| Cardinal Health (CAH) | 2.0 | $7.9M | 105k | 74.92 | |
| Mallinckrodt Pub SHS | 1.8 | $7.2M | 80k | 90.15 | |
| Illumina (ILMN) | 1.8 | $7.0M | 43k | 163.93 | |
| Centene Corporation (CNC) | 1.6 | $6.5M | 79k | 82.70 | |
| Regeneron Pharmaceuticals (REGN) | 1.6 | $6.5M | 18k | 360.50 | |
| Teva Pharmaceutical Inds Adr (TEVA) | 1.6 | $6.5M | 120k | 53.75 | |
| Allergan | 1.6 | $6.2M | 35k | 178.20 | |
| Molina Healthcare (MOH) | 1.4 | $5.5M | 131k | 42.30 | |
| ISIS Pharmaceuticals | 1.4 | $5.4M | 140k | 38.83 | |
| Catamaran | 1.3 | $5.2M | 137k | 38.37 | |
| Proshares Tr Pshs Ult Nasb (BIB) | 1.3 | $5.2M | 50k | 103.98 | |
| Covidien SHS | 1.3 | $5.2M | 60k | 86.52 | |
| Qiagen Nv Reg Shs | 1.3 | $5.2M | 251k | 20.71 | |
| Eli Lilly & Co. (LLY) | 1.3 | $5.2M | 80k | 64.85 | |
| Aetna | 1.2 | $4.9M | 60k | 81.00 | |
| Johnson & Johnson (JNJ) | 1.2 | $4.8M | 45k | 106.60 | |
| Baxter International (BAX) | 1.2 | $4.7M | 65k | 71.77 | |
| Stryker Corporation (SYK) | 1.2 | $4.6M | 58k | 80.75 | |
| Humana (HUM) | 1.1 | $4.6M | 35k | 130.29 | |
| WellPoint | 1.1 | $4.5M | 38k | 119.63 | |
| CIGNA Corporation | 1.1 | $4.5M | 50k | 90.70 | |
| Brookdale Senior Living (BKD) | 1.1 | $4.4M | 138k | 32.22 | |
| Dr Reddys Labs Adr (RDY) | 1.0 | $4.2M | 80k | 52.55 | |
| Perrigo SHS (PRGO) | 1.0 | $4.1M | 31k | 134.96 | |
| Express Scripts Holding | 1.0 | $4.0M | 57k | 70.63 | |
| St. Jude Medical | 1.0 | $3.9M | 65k | 60.12 | |
| Lannett Company | 0.9 | $3.7M | 80k | 45.67 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $3.6M | 50k | 72.16 | |
| CVS Caremark Corporation (CVS) | 0.9 | $3.6M | 45k | 79.60 | |
| Incyte Corporation (INCY) | 0.9 | $3.4M | 70k | 49.06 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.8 | $3.2M | 20k | 160.55 | |
| Hca Holdings (HCA) | 0.8 | $3.2M | 45k | 70.51 | |
| Insulet Corporation (PODD) | 0.7 | $2.9M | 80k | 36.85 | |
| ResMed (RMD) | 0.7 | $2.9M | 60k | 49.27 | |
| Shire Sponsored Adr | 0.7 | $2.8M | 11k | 259.09 | |
| Endo Intl SHS (ENDPQ) | 0.7 | $2.7M | 40k | 68.35 | |
| Bristol Myers Squibb (BMY) | 0.6 | $2.6M | 50k | 51.18 | |
| Zimmer Holdings (ZBH) | 0.6 | $2.5M | 25k | 100.56 | |
| Revance Therapeutics (RVNC) | 0.6 | $2.5M | 130k | 19.33 | |
| Cerner Corporation | 0.6 | $2.4M | 40k | 59.58 | |
| Merck & Co (MRK) | 0.6 | $2.4M | 40k | 59.27 | |
| Akorn | 0.5 | $2.2M | 60k | 36.27 | |
| Medivation | 0.5 | $2.0M | 20k | 98.85 | |
| United Therapeutics Corporation (UTHR) | 0.5 | $1.9M | 15k | 128.67 | |
| Alkermes SHS (ALKS) | 0.5 | $1.9M | 45k | 42.87 | |
| Direxion Shs Etf Tr Dly Smcap Bull3x (TNA) | 0.5 | $1.9M | 30k | 63.40 | |
| DaVita (DVA) | 0.5 | $1.9M | 26k | 73.15 | |
| Intuitive Surgical Com New (ISRG) | 0.5 | $1.8M | 4.0k | 461.75 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $1.8M | 23k | 78.09 | |
| Pfizer (PFE) | 0.4 | $1.8M | 60k | 29.57 | |
| MannKind Corporation | 0.4 | $1.8M | 300k | 5.91 | |
| Theravance | 0.4 | $1.7M | 100k | 17.09 | |
| Ariad Pharmaceuticals | 0.4 | $1.6M | 300k | 5.40 | |
| Varian Medical Systems | 0.4 | $1.6M | 20k | 80.10 | |
| Cubist Pharmaceuticals | 0.4 | $1.6M | 24k | 66.33 | |
| Seattle Genetics | 0.4 | $1.5M | 40k | 37.17 | |
| Edwards Lifesciences (EW) | 0.4 | $1.5M | 15k | 102.14 | |
| C.R. Bard | 0.4 | $1.4M | 10k | 142.70 | |
| athenahealth | 0.3 | $1.3M | 10k | 131.70 | |
| Wright Medical | 0.3 | $1.2M | 38k | 30.29 | |
| Omnicare | 0.3 | $1.1M | 18k | 62.28 | |
| Medicines Company | 0.3 | $1.1M | 50k | 22.32 | |
| Ldr Hldg | 0.3 | $1.0M | 33k | 31.12 | |
| Myriad Genetics (MYGN) | 0.2 | $926k | 24k | 38.58 | |
| NPS Pharmaceuticals | 0.2 | $884k | 34k | 26.00 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $867k | 35k | 24.77 | |
| Affymetrix | 0.2 | $798k | 100k | 7.98 | |
| Achillion Pharmaceuticals | 0.2 | $798k | 80k | 9.97 | |
| AmerisourceBergen (COR) | 0.2 | $773k | 10k | 77.30 | |
| Neurocrine Biosciences (NBIX) | 0.2 | $705k | 45k | 15.67 | |
| Immunomedics | 0.1 | $558k | 150k | 3.72 | |
| Halozyme Therapeutics (HALO) | 0.1 | $546k | 60k | 9.10 | |
| WellCare Health Plans | 0.1 | $483k | 8.0k | 60.38 | |
| Impax Laboratories | 0.1 | $474k | 20k | 23.70 | |
| Exelixis (EXEL) | 0.1 | $459k | 300k | 1.53 | |
| Celldex Therapeutics | 0.1 | $389k | 30k | 12.97 | |
| Organovo Holdings | 0.1 | $319k | 50k | 6.38 | |
| Theravance Biopharma (TBPH) | 0.1 | $263k | 11k | 23.01 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $228k | 17k | 13.41 | |
| Geron Corporation (GERN) | 0.0 | $90k | 45k | 2.00 | |
| Dendreon Corporation | 0.0 | $72k | 50k | 1.44 | |
| Cubist Pharmaceuticals Right 99/99/9999 | 0.0 | $9.0k | 80k | 0.11 |
